We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Ingestible Marker Reliably Tracks Ingestion Events

By HospiMedica International staff writers
Posted on 24 Dec 2019
A novel ingestible event marker helps clinicians overcome the challenges of patient non-adherence to medication regimens.

The etectRx (Gainesville, FL, USA) ID-Cap system is comprised of a gelatin capsule (the ID-Capsule) which contains the ID-Tag, a sensor that emits a low-power digital signal from inside the patient to monitor real-time, dose-level ingestion event verification. More...
After it is ingested and activated by the patient's stomach fluid, it transmits signals to the wearable ID-Cap reader, which verifies the signal as a valid ingestion event and forwards the data to a secure, smartphone-based mobile application and to the healthcare provider via Dashboard, a secure web-based portal.

The ID-Cap System is intended to log, track, and trend intake times in order to enable unattended data collection of medication adherence for a range of clinical applications. It may be used when quantifiable analysis of ingestion events is needed, including events signaled by the co-ingestion with the ID-Capsule. Eventually, after the ID-Cap capsule dissolves, the ultra-thin, flexible ID-Tag sensor is eliminated via the gastrointestinal (GI) tract.

“The technology could enable doctors to better know if their patients are compliant with a therapy regimen and tailor their treatment practices, based on real-world use data,” said Harry Travis, CEO of etectRx. “A patient swallows their pill, they have their reader on, and within a few minutes of swallowing their pill, they get a notification on their cell phone that says, ‘Thank you for taking your medicine’.”

Estimates by the World Health Organization (WHO, Geneva, Switzerland) indicate that only about 50% of patients in developed countries follow treatment recommendations. Low rates of adherence for asthma, diabetes, and hypertension are thought to contribute substantially to the human and economic burden of those conditions. Major barriers to compliance include the complexity of modern medication regimens, poor "health literacy" and lack of comprehension of treatment benefits, undiscussed side effects, the cost of prescription medicine, and poor communication or lack of trust between patient and health-care provider.

Related Links:
etectRx
World Health Organization



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
12-Lead Electrocardiograph
ASPEL ECG GREY v.07.325
New
Critical Care Cart
Avalo
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.